Cancer Patients Raise Alarm Over New SHA Treatment Guidelines

Written by

in

The revised system, introduced to standardise cancer treatment and make healthcare more affordable, has reportedly created difficulties for patients seeking chemotherapy, diagnostic tests and other specialised services.

Some patients have complained about rejected treatment requests, reduced drug approvals, additional out-of-pocket payments and delays caused by the new authorisation procedures.

At Jaramogi Oginga Odinga Teaching and Referral Hospital, only 12 out of 30 oncology treatment requests submitted on Monday were reportedly approved by SHA.

Even some patients whose requests were approved were required to make additional payments before receiving treatment.

The changes have also introduced several approval stages involving nurses, oncologists and pharmacists, with patients reporting longer waiting periods as requests go through the system.

However, SHA maintains that the new guidelines are intended to improve cancer care by standardising treatment costs and ensuring patients receive appropriate medication.

The authority has also clarified that the annual cancer treatment benefit of Sh800,000 remains unchanged, dismissing concerns that the cover has been reduced.

Health Cabinet Secretary Aden Duale has announced further reforms aimed at addressing the challenges, including a single pre-authorisation covering multiple treatment cycles and unified patient records across contracted hospitals.

The government says the changes will reduce paperwork, minimise delays and allow patients to receive approved treatment at different contracted facilities.

Meanwhile, cancer specialists have urged SHA to address the operational challenges to ensure administrative procedures do not interrupt essential treatment.

They warn that delays in chemotherapy, radiotherapy and diagnostic services can have serious consequences for patients.

Source

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *